Seebri Breezhaler

Seebri Breezhaler Contraindications

glycopyrronium bromide

Manufacturer:

Novartis Indonesia

Marketer:

Wellesta
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Contraindications
Hypersensitivity to glycopyrronium or to any of the excipients of Seebri Breezhaler.
Should not be used in patients <18 years of age. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in